Kalehua Capital Management LLC
Source: SEC Form 13F · as of Mar 2026Kalehua Capital Management LLC holds 15 biotech & pharma companies tracked by BioSniper, totaling $159.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$159.3M
BioSniper AIPage evidence connected
Prepared research question
What matters most for X4 Pharmaceuticals, Inc (XFOR)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| XFORX4 Pharmaceuticals, Inc | 7,445,680 | $30.8M |
| SRZNSurrozen Inc. | 770,356 | $22.4M |
| SIONSionna Therapeutics, Inc. | 394,144 | $15.8M |
| MANEVeradermics Incorporated | 248,574 | $15.7M |
| ORKAOruka Therapeutics, Inc. | 237,048 | $11.6M |
| PHVSPharvaris N.V. | 397,544 | $11.2M |
| CMPSCOMPASS Pathways plc | 1,639,384 | $9.1M |
| RLAYRelay Therapeutics, Inc. | 901,457 | $9.0M |
| QUREuniQure N.V. | 502,811 | $8.2M |
| LONALeonaBio, Inc. | 787,402 | $8.1M |
| DMRADamora Therapeutics, Inc. | 278,000 | $7.2M |
| MLTXMoonLake Immunotherapeutics | 351,468 | $6.6M |
| KLRSKalaris Therapeutics, Inc. | 271,170 | $1.6M |
| KRROKorro Bio, Inc. | 109,376 | $1.2M |
| DMACDiaMedica Therapeutics Inc. | 124,976 | $846K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.